SCOOT
Research type
Research Study
Full title
Sample Collection for The Integration and Analysis of Data Using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases
IRAS ID
306757
Contact name
N/A RGEA
Contact email
Sponsor organisation
University of Oxford
Duration of Study in the UK
2 years, 4 months, 31 days
Research summary
Lung Cancer is the second most common Cancer in the UK and the most lethal. Unfortunately, more than 75% of lung cancers in the UK are diagnosed late, and the 5-year survival rate for these patients is very low (5%).
Recently blood tests have been thought to be helpful in diagnosing lung cancer, and in this study we plan to take blood from patients that have a nodule suspected of being cancer (5000 patients). Taking blood samples from these patients will allow SCOOT to test if blood biomarkers can be used to help to predict whether a detected nodule suspected of being a lung cancer is cancerous or not.REC name
Yorkshire & The Humber - South Yorkshire Research Ethics Committee
REC reference
22/YH/0064
Date of REC Opinion
10 Mar 2022
REC opinion
Favourable Opinion